Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040022 | SCV000063713 | uncertain significance | not specified | 2012-03-16 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Ala7119Ser vari ant in TTN has been identified in 0.2% (7/2996) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.was hington.edu/EVS). Computational analyses (biochemical amino acid properties, con servation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. While this frequency suggests that Ala7119Ser variant is more likely benign, it is too low to confidently rule out a disease c ausing role. Additional information is needed to fully assess its clinical signi ficance. |
Genetic Services Laboratory, |
RCV000118744 | SCV000153211 | uncertain significance | not provided | 2013-08-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000118744 | SCV000238358 | likely benign | not provided | 2020-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087646 | SCV000555200 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000040022 | SCV000616032 | uncertain significance | not specified | 2017-06-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000118744 | SCV000855157 | uncertain significance | not provided | 2018-07-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000040022 | SCV001921327 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000040022 | SCV001970977 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541139 | SCV004758559 | likely benign | TTN-related disorder | 2023-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |